SARS-CoV-2 Infection and Factors Associated with Mortality in Hospitalized Patients Aged 60 and Over at the Epidemic Treatment Center (ETC) of Saint-Louis (Senegal)
Alassane Dièye, Arona Diouf, Papa Latyr Junior Diouf, Moustapha Diedhiou, Mba Bambo Diakhaby, Demba Makalou, Samba Niang, Diatou Dia-Gueye, Amadou Diop Dia, Ibrahima Louis Martin Dieng, Ahmeth Dieng, Seynabou LO, Ndéye Méry Dia-Badiane
Asian Journal of Research in Infectious Diseases · pp. 13–23 · Published 23 Feb 2024
10.9734/ajrid/2024/v15i2327Abstract
Background: SARS-CoV-2 infection typically causes severe pneumonia in elderly patients with high mortality rates. Aim: This study aimed to describe the epidemiological, clinical, paraclinical and evolution profile of the SARS-CoV-2 infection in patients aged 60 years and over hospitalized at the Epidemic Treatment Center (ETC) of Saint-Louis “Senegal”, and to identify the factors associated with death. Methodology: This is a cross-sectional, retrospective, descriptive and analytical study conducted from March 2020 to August 2021. It includes all patients aged 60 years and older hospitalized at the ETC of Saint-Louis (Senegal) for SARS-CoV-2 infection. Microsoft Excel was used to enter data and then analysis was done using EPI INFO version 7 software. Results: Of a total of 448 hospitalizations, 188 patient records aged 60 years and older was collected. The prevalence was 42%. The mean age was 70 years (±8 years). The sex ratio was 1.7 with a male predominance (62.8%). Hypertension was the most common co-morbidity (67%). Severe forms were predominant (64.4%). Dyspnea (60.3%), cough (56.5%) and ageusia (24.5%) were the most common symptoms on admission. Thoracic CT scans showed severe involvement in 51.7% of cases. Hydroxychloroquine-azithromycin combination was prescribed in 98.4% of cases. The mortality rate was 18.6%. The main factors associated with death were age (≤75 years) (p=0.014) [OR=0.488; 95% CI: 0.201-1.187]; critical forms (p=0.017) [OR=0.061; 95% CI: 0.006-0.601]; comorbidity (p=0. 031) [OR=1.647; 95% CI: 0.280-2.499]; occurrence of complications (p=0.009) [OR=1.212; 95% CI: 0.530-2.774]; and SpO2≤95% at admission (p=0.031) [OR=4.899; 95% CI: 0.752-8.797]. Conclusion: SARS-CoV-2 infection in the elderly is predominantly severe with high mortality. This high-risk group requires special attention.
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.